LBPO.CL03 · 临床研究 · Late-Breaking

修订日本保险制度与患者倡导活动

Revising Japan's insurance system and patient advocacy activities

编号 LB325 展板 6 时间 4/21 02:00–05:00 区域 Section 52 主讲 Naomi Sakurai, BA
分会场 Late-Breaking Research: Clinical Research 3
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Naomi Sakurai1, Shinsuke Amano1, Hiromi Todoroki1, Yoko Matsumoto1, Yoshiyuki Majima1, Maiko Higuchi1, Mina Katome1, Ruri Kobayashi1, Ayako Yago1, Yuka Tsujimoto1, Yuri Ito2

1Japan Federation of Cancer Patient Groups, Tokyo, Japan,2Osaka Medical and Pharmaceutical University, Osaka, Japan

摘要 Abstract

中文摘要
关于我们:日本癌症患者团体联合会成立于纪念日本《癌症对策基本法》颁布10周年之际。它是一个全国性联盟,涵盖日本各地50个患者团体,成员超过30,000人。 发生了什么?:日本拥有全民健康保险制度。例如,一名平均收入的工作年龄个人需自付其医疗费用的30%。除此之外,还有一项制度:如果使用高价药物且医疗费用超过根据收入决定的一定金额,超出部分将获得退还。如果费用超过一定金额,即可获得退款。在接受昂贵的医疗治疗时,这一制度是极大的帮助。然而,2024年12月,政府突然提出一项修订,将工作人群的高额医疗费用上限最高提高170%。这真正震惊了我们。工作年龄的癌症患者将无法达到高额医疗费用福利上限,不得不继续支付高昂的治疗费用。 我们的行动:1. 我们于2024年12月中旬立即向国家政府提交了请求。2. 我们收集了3,626名患者关于经济毒性的故事,以及135,287人的签名。3. 我们提供了关于癌症诊断对就业、收入和治疗持续性影响的数据。4. 在医疗经济学专家的帮助下,我们模拟了如果实施修订会发生什么。我们向厚生劳动省递交请愿书,要求停止变更并重新考虑。接下来,我们呼吁患者讲述他们关于经济毒性的故事。然后我们发起了一项收集签名的活动。我们还请求学术团体就此事发表声明,因为该修订将使许多工作年龄的患者无法继续治疗。我们与各政党的国会议员举行了会议。在医疗经济学专家的帮助下,我们模拟了如果实施修订会发生什么。我们发现太多的工作年龄人口将陷入遭受灾难性医疗费用的境地。这是WHO定义为可持续发展目标(SDGs)之一的概念。最终,首相会见了我们,倾听了患者团体的声音,并决定暂时中止并审查高额医疗费用制度的修订。 我们为何成功:1. 使用数据与叙事性患者声音相结合。2. 与学术团体、健康经济学和公共卫生专家,以及罕见病和不治之症患者团体合作。3. 利用媒体,包括社交网络服务。正是患者和公民的声音,阻止了这一原本将在没有充分讨论的情况下实施的不合理变更。这是日本政治史上首次发生此类中止。 总结:我们发现,与患者的声音、学术团体、公共卫生和健康经济学专家共同创造,能够对医疗政策产生重大影响。确保患者获得治疗从健康差异的角度来看是一个重要议题,而建立公平的社会保障制度是关键。
查看英文原文 English abstract
About us: Japan Federation of Cancer Patient Groups was established to celebrate the 10th anniversary of the National Cancer Control Act in Japan. It is a national coalition involving 50 patient groups across Japan, membership exceeding 30,000 people. What happened?: Japan has a universal health insurance system. For example, a working age individual with average income pay 30% of their medical costs out of pocket. In addition to that, there is a system in place where, if high cost medications are used and medical costs exceed a certain amount that is decided depending on income, the excess amount is refunded. If expenses exceed a certain amount, you receive a refund. This system is a great help when undergoing expensive medical treatment. However, in December 2024, the government suddenly proposed a revision that would raise the upper limit on high-cost medical care expenses for working people by up to 170%. This truly shocked us. Working age cancer patients would not be able to reach the high cost medical care benefit cap and would have to continue paying high treatment costs. Our Actions: 1. We immediately submitted a request to the national government in mid-December 2. We gathered stories about financial toxicity from 3,626 patients, and signatures from 135,287 individuals. 3.We presented data on the impact of cancer diagnosis on employment, income, and treatment continuation. 4.With help of healthcare economics experts, we simulated what would happen if the revisions were implemented. We sent a petition to the Ministry of Health, Labour and Welfare demanding a halt to the changes and to reconsider. Next, we called out for patients to give their stories about financial toxicity. Then we launched a campaign to collect signatures. We also requested academic societies to issue statements about the matter, because the revision will make many working age patients unable to continue treatment. We held meetings with Diet members of various political parties. With help of healthcare economics experts, we simulated what would happen if the revisions were implemented. We found that too many of the working-age population would fall into a situation suffering from catastrophic medical expenses. This is a concept defined by the WHO as one of the SDGs goals. Finally, the Prime Minister met us and listened to the voices of patient groups and He decided to temporarily suspend and review the revision of the high cost medical expense system. Why We Succeeded: 1.Using data with narrative patient voices. 2.Collaborating with academic societies, experts in health economics, and public health, as well as patient groups for rare and incurable diseases. 3. Utilizing media, including social networking services. It was the voices of patients and citizens that stopped this unreasonable change which was going to be implemented without sufficient discussion It was the first time that this kind of halt happened in the Japan's political history. Summary: We found that co-creation with patients' voices, academic societies, public health, and health economics experts can have a significant impact on healthcare policy. Ensuring patient access to treatment is an important topic from the perspective of health disparities, and developing a fair social security system is key.
利益披露 Disclosure
N. Sakurai, None.. S. Amano, None.. H. Todoroki, None.. Y. Matsumoto, None.. Y. Majima, None.. M. Higuchi, None.. M. Katome, None.. R. Kobayashi, None.. A. Yago, None.. Y. Tsujimoto, None.. Y. Ito, None.

← 返回 AACR 2026 检索